Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.19 USD | -0.35% | +0.97% | -45.02% |
04-30 | UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating | MT |
04-23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
- Stock Market
- Equities
- ACAD Stock
- News ACADIA Pharmaceuticals Inc.
- MarketScreener Strategies